Vincristine Pharmacokinetics in Infants
A Pharmacokinetic Study of VinCRIStine in Infants Dosed According to BSA-Banded Infant Dosing Tables and Older Children Dosed by Traditional BSA Methods
Sponsor: Children's Oncology Group
A observational or N/A phase clinical study on Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, this trial is ongoing. The trial is conducted by Children's Oncology Group and has accumulated 19 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
19 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Dec 2025 — Feb 2026 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2025 — Dec 2025 [monthly]
Recruiting
-
Sep 2025 — Nov 2025 [monthly]
Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Recruiting
▶ Show 14 earlier versions
-
Nov 2024 — Jan 2025 [monthly]
Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Nov 2023 — Apr 2024 [monthly]
Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Recruiting
-
May 2023 — Oct 2023 [monthly]
Recruiting
-
Apr 2023 — May 2023 [monthly]
Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Recruiting
Phase: EARLY_PHASE1 → None
-
Jan 2023 — Feb 2023 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2022 — Dec 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .